Summary Twenty-one days after s.c. subscapular transplantation of a radiation-induced insulinoma, male NEDH rats exhibited hyperinsulinaemia and hypoglycaemia. These features were associated with islet atrophy, degenerative changes in pancreatic A and B cells, and decreases in the pancreatic contents of insulin, glucagon and somatostatin. The immunoreactive glucagon and somatostatin contents of extrapancreatic tissues of insulinoma-bearing rats were unchanged. Surgical resection of the tumour resulted in an immediate fall of plasma insulin, attaining concentrations similar to those of anaesthetised control rats by 0 min. The estimated half-life of insulin was 3.5 min. Hypoglycaemia persisted until 60 min after resection, followed by hyperglycaemia of 1-2 days duration. Glucose tolerance was impaired 1 day after tumour resection despite the coexistence of raised insulin concentrations. Evidence for abnormal pancreatic B cell function was gained by injection of arginine which failed to evoke a plasma insulin response in the resected rats. Two days after resection, plasma glucose and insulin concentrations were similar to those of control rats. Plasma glucose and insulin responses to glucose and arginine were suggestive of tumour recurrence by 12 days. A single large encapsulated tumour was eventually observed in each rat, with resection giving a 17-56 day prolongation of life.
Study of insulin-secreting tumours (insulinomas), the most common type of enteropancreatic endocrine cancer, has been limited by difficulties of diagnosis and the sporadic incidence of the disease in man (Editorial, 1981; Marks & Rose, 1981; Friesen, 1982) . Attention has recently been given to the induction of serially transplantable insulinomas in animals, which provide useful models to assist elucidation of the underlying cellular defects and the metabolic effects of insulinomas on the regulation of glucose homeostasis. Transplantable islet cell tumours have been established from single pancreatic tumours in hamsters and rats which have arisen either spontaneously, after BK virus innoculation, streptozotocin-nicotinamide injection or X-ray irradiation (Grillo et al., 1967; Hirayama et al., 1979; Chick et al., 1977 Chick et al., , 1980 . The transplantable NEDH rat insulinoma, developed in the irradiated partner of a pair of parabiont NEDH rats (Chick et al., 1977) , offers the advantage of high insulin content and rapid growth rate, resulting consistently in the production of a localised, highly vascularised encapsulated tumour at the subscapular implantation site. In insulinoma-bearing rats of the Surrey subline, tumour growth is accompanied by the development of marked hyperinsulinaemia and hypoglycaemia, leading to neuroglycopaenic coma within one month (Flatt et al., 1986a) . The present study examines the short and longer-term effects of tumour resection on glucose homeostasis and the morphology, hormone content and function of the endocrine pancreas in recipient NEDH rats. In addition, the effects of insulinoma transplantation on glucagon and somatostatin stores have been examined in selected extrapancreatic tissues.
Materials and methods

Animals
Male inbred albino NEDH (New England Deaconess Hospital) rats from the colony at the University of Surrey carrying a serially transplantable radiation-induced insulinoma (Chick et al., 1977) Experimental procedure Two groups of 12 tumour-bearing rats transplanted 21 days previously and two groups of 12 control rats were used. In the first experimental series, the rats were killed by cervical dislocation, and the pancreas, stomach, duodenum, jejunum, ileum, colon, kidney and hypothalamus were excised, cleaned in ice-cold 0.9% NaCl and weighed. A small piece of the pancreas tail was fixed for 24 h in neutral buffered formalin, dehydrated through graded ethanols, cleared in toluene and embedded in paraffin wax for histological and immunocytochemical investigation. The remaining pancreatic tissue was reweighed and all tissues were extracted with 5mlg-1 acid-ethanol (750ml ethanol, 250ml water, 15 ml concentrated hydrochloric acid) as described previously (Flatt et al., 1983) . All tissue extracts were analysed for immunoreactive insulin and somatostatin. Glucagon-like immunoreactivity was monitored in extracts of pancreas, duodenum and ileum.
In the second experimental series, plasma glucose and insulin concentrations were monitored immedately before and after tumour resection at the times shown in Figure 1 
Assays
Plasma glucose was measured by an automated glucose oxidase procedure (Stevens, 1971) . Insulin was determined by dextran-charcoal radioimmunoassay (Flatt & Bailey, 1981) using guinea pig antiporcine insulin antiserum (GPB1; PRF/SKS-F), 125I-bovine insulin tracer (Amersham International, Amersham, UK) and rat insulin standard (Novo Industria, Copenhagen, Denmark). Glucagon-like immunoreactivity and somatostatin were also measured by modified dextran-charcoal radioimmunoassays (Penman et al., 1979; Flatt & Swanston-Flatt, 1981) using fully cross-reacting Nterminal guinea pig antiporcine glucagon antiserum (GPC1/2: Flatt & Swanston-Flatt, 1981) and rabbit anticyclic somastostatin antiserum (RG; Penman et al., 1979) respectively. 125I-porcine glucagon (J0rgensen & Larsen, 1972) and 1251-tyrosylated cyclic somatostatin (Penman et al., 1979) Rehydrated paraffin sections (5 gm) were stained with haematoxylin and eosin, or immunostained by the indirect immunoperoxidase technique using guinea pig anti-porcine insulin antiserum (GPB3; PRF/SKS-F), guinea pig anti-porcine glucagon antiserum (GPC4; Flatt & Swanston-Flatt, 1981) and affinity purified donkey anti-guinea pig immunoglobulin G conjugated to horseradish peroxidase (Guildhay Antisera, University of Surrey, Guildford, UK). Somatostatin and PP were immunostained by the unlabelled peroxidase antiperoxidase (PAP) technique (Sternberger, 1979) using the following antisera: rabbit anti-cyclic somatostatin (GR21A; Guildhay Antisera), rabbit anti-bovine pancreatic polypeptide (GR39PD; Guildhay Antisera), donkey anti-rabbit immunoglobulin G (Guildhay Antisera) and rabbit PAP complex (Dakopatts, Glostrup, Denmark). Peroxidase activity was visualised using 3,3'-diaminobenzidine (British Drug Houses, Poole, UK) and sections were counterstained with Harris haematoxylin (British Drug Houses). Control sections were treated with normal serum instead of the hormone antisera.
Statistical analysis
Values are presented as mean + s.e., and groups of data were compared using Student's paired and unpaired t-tests. Differences were considered to be significant for P<0.05. , Minutes Hrs Days
Results
Implantation of tumour fragments resulted in the development of a single subscapular tumour in each rat by 21 days. This was accompanied by a marked increase in plasma insulin and decrease in plasma glucose (73 + 14 ng ml -I and 2.5 + 0.4 mmol I -1, n = 12, respectively) compared with control rats (3.5+0.5ngml-1 and 6.4+0.2mmoll-1, n=12) as shown in Figure 1 . At 21 days the tumour-bearing rats exhibited greatly reduced pancreatic contents of insulin and somatostatin (95% and 80% reductions respectively), and a smaller decrease (58%) in pancreatic glucagon (Figure 2 ). In contrast, the immunoreactive somatostatin and glucagon contents of selected extra-pancreatic tissues were not significantly changed in the tumour-bearing rats (Table I) . With the exception of the pancreas, none of the tissue extracts analysed contained detectable amounts of immunoreactive insulin.
Histological and immunocytochemical examination of sections of pancreas tail 21 days after tumour transplantation confirmed and extended the measurements of pancreatic hormone contents. The islets were reduced in size, and their general morphology is illustrated by haematoxylin and eosin staining of a typical atrophic islet in Figure 3a towards the centre of the islet appeared normal. Immunocytochemical staining for insulin, glucagon and somatostatin in adjacent sections of the same islet is shown in Figure 4 . Compared with sections from control rats (Figure 4d ), the islets of tumourbearing rats revealed a central core of B cells with weak immunocytochemical staining for insulin (Figure 4a ). Peripherally located glucagon staining A cells frequently showed degenerative changes (Figure 4b ), while the small number of scattered and clumped peripheral somatostatin staining D cells were normal in appearance (Figure 4c ). Although PP containing cells were infrequent in the pancreas tail of control NEDH rats, islets from this region were almost entirely devoid of PP cells in tumour-bearing rats. As shown in Figure 1 , surgical resection of the tumour at day 21 resulted in a prompt and marked reversal of the metabolic abnormalities of insulinoma-bearing rats. Plasma insulin concentrations fell rapidly to the range of anaesthetised controls within 10min, corresponding to an estimated insulin half-life of -3.5 min. Despite this fall, hypoglycaemia persisted until 60min followed by hyperglycaemia for 1-2 days. It is noteworthy that recovery from anaesthesia (approximately 120 minutes) produced a small rise in plasma glucose concentrations in control rats.
The transient diabetes 1 day after tumour resection was confirmed by intraperitoneal glucose tolerance tests (Figure 5a ) which showed impaired glucose homeostasis despite slightly higher plasma insulin concentrations both before and after administration of glucose. Evidence for abnormal pancreatic B cell function was gained by intraperitoneal injection of arginine (Figure 5b) , which failed to evoke a plasma insulin response 1 day after resection. Two days after tumour resection, basal plasma glucose and insulin concentrations were similar to control rats and remained so until day 12 when basal insulin values were slightly raised (Figure 1 ). At this time glucose tolerance was improved compared with control rats and insulin concentrations remained slightly higher during the test (Figure 6a ). The accelerated rate of glucose clearance, with the loss of an insulin response to glucose may provide early evidence of tumour recurrence. Moreover, the insulin response to arginine was impaired 12 days after tumour resection (Figure 6b) . A single large tumour was eventually observed at the original subscapular site in each of the resected rats. Resection gave a 17-56 day (32+4 day, n=12) prolongation of life (55+4 days since original tumour transplant) compared with the survival of similarly transplanted unresected insulinoma-bearing rats (24 + 1 days, n =9). 
Discussion
Consistent with previous reports, subscapular implantation of tumour fragments resulted by 21 days in the development of a large encapsulated tumour in each rat with associated hyperinsulinaemia and hypoglycaemia (Flatt et al., 1986a) . The position of the tumour at the implantation site and the presence of a connective tissue capsule greatly facilitated surgical resection. Excision of the tumour was associated with a prompt and marked reversal of the abnormalities of glucose homeostasis. However, despite scrupulous and extensive cleansing of the excision site, local tumour recurrence was observed in each rat, with resection affording a 17-56 day prolongation of life. This may reflect direct tissue invasiveness of these tumours or unavoidable contamination of the subscapular area with tumour cells during the resection procedure. Indeed, subscapular implantation of a small number of isolated tumour cells has previously been shown to reproduce the effects of routine tumour fragment transplantation (Flatt et al., 1986b) . The observation that tumour recurrence was restricted to the original subscapular site is consistent with the very rare tendency of the tumour to form metastases (Chick et al., 1977; Flatt et al., 1986b) . In this context, it is noteworthy that plasma insulin concentrations declined rapidly to the normal range after resection, and that no detectable insulin was found in the various extrapancreatic tissues of tumour-bearing rats.
As noted using routine histological staining, tumour-bearing rats of the Boston subline exhibited marked atrophy and degranulation of B cells in the pancreas (Chick et al., 1977) . The present study has confirmed and extended these observations by direct hormone assay and specific immunohistochemistry of the principal islet cell types. This approach demonstrated a generalised atrophy of the islets associated with irregular peripheral boundaries containing detached glucagoncontaining A cells with pyknotic nuclei and shrunken B cells with karyorrhetic nuclei. Peripheral islet D cells containing somatostatin appeared normal but the central B cell mass exhibited a weak immunocytochemical staining for insulin, and PP-staining cells were reduced in number. These changes were accompanied by marked decreases of insulin, glucagon and somatostatin in the pancreas of the tumour-bearing rats. It is likely that the hyperinsulinaemia, resulting from unchecked tumour insulin secretion, and not the accompanying hypoglycaemia is primarily responsible for the generalised suppression of islet cells. Thus unlike glucose which has divergent effects on islet hormone secretions, insulin inhibits the secretion of insulin, glucagon, somatostatin, and PP (Bailey, 1980; Schauder & McIntosh, 1980; Floyd & Vinik, 1981; Samols et al., 1983) , and specific insulin receptors have been demonstrated on islet cells (Verspohl & Ammon, 1980; Bhathena et al., 1982) . In contrast to the pancreas, the glucagon and somatostatin contents of extrapancreatic tissues were unchanged in insulinomabearing rats. This clearly reflects the specialised functions of the pancreatic A and D cells in the control of islet hormone secretions and the regulation of nutrient homeostasis.
Resection of the tumour under pentobarbitone anaesthesia resulted in a marked reduction of plasma insulin, corresponding to an estimated halflife of 3.5minutes. This compares favourably with published values for the disappearance of insulin in the anaesthetised rat (Izzo, 1975; Frayn, 1976) , and indicates that the hyperinsulinaemia of insulinomabearing rats is maintained by a high rate of insulin secretion from the tumour. The decline of plasma insulin after resection was paralleled by a progressive rise in glycaemia, achieving glucose concentrations approximately two-fold higher than anaesthetised controls by 120 minutes. The anaesthesia may have contributed to the hyperglycaemic action (Bailey & Flatt, 1980) . However, rebound hyperglycaemia persisted for at least 24 hours indicating a brief intervening period of impaired glucose homeostasis after tumour removal. This corresponds with earlier observations in NEDH rats of the Boston subline which were attributed to suppression of insulin secretion by the host pancreatic B cells (Chick et al., 1977) . Measurement of plasma insulin concentrations refutes this view, since at no time following resection did circulating insulin fall below the range of control rats. This suggests that impaired action of insulin rather than impaired secretion is responsible for the hyperglycaemia. Indeed, it is not difficult to envisage down-regulation of peripheral insulin receptors in the hyperinsulinaemic state (Bailey et al., 1984; Gammeltoft, 1984) which would recover to restore insulin sensitivity shortly after resection. This view is supported by impaired glucose tolerance of 1 day resected rats despite raised insulin concentrations during the test. However, insulin secretory responsiveness was also impaired in these animals, as illustrated by the lack of effect of arginine. Consistent with tumour recurrence, the plasma glucose and insulin responses to these agents had reverted by 12 days to those typically observed in insulinoma-bearing rats.
In conclusion, the similarity of the changes induced by the transplantable NEDH rat insulinoma to those established from isolated studies in man (Editorial, 1981; Marks & Rose, 1981; Friesen, 1982) , indicates the suitability of these rats as an animal model for studies on the basic nature and properties of spontaneous insulinomas. However, it must be stressed that experimentally-induced islet-cell tumours differ considerably, and that careful characterisation of each tumour cell line must be undertaken to establish its potential usefulness. Indeed tumours derived from the same source may also develop fundamental differences, as illustrated by the divergence between the 4-5 month survival time originally reported (Chick et al., 1977) and the life expectancy found in the Surrey subline. These studies were supported by a grant from the Cancer Research Campaign (SP1630).
